Cataract Surgery Devices Market

Global Cataract Surgery Devices Market By Type (Equipment, Consumables), Product (Intraocular Lens, Ophthalmic Viscoelastic Device, Phacoemulsification Equipment), End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers)

Report Id: KBV-1454 Publication Date: February-2019 Number of Pages: 192
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Global Cataract Surgery Devices Market size is expected to reach $10.0 billion by 2024, rising at a market growth of 4.8% CAGR during the forecast period. Cataract surgery devices are majorly used in surgical procedures that are focused on treating cataract, an eye disorder which clouds the lens, and as a result, leads to defects in vision. Cataract is among the most common diseases which leads to blindness, reducing vision ability. Cataract is known to develop slowly and affects either one or both the eyes. Cataract does not directly interfere with the eyesight in its early stages; nevertheless, it interferes with vision and leads blindness over the years. Increase in incidences of diseases such as diabetes, obesity, hypertension and growth in geriatric population contributes to the growth of the market.

Cataract surgery devices are majorly used in surgical procedures that are focused on treating cataract, an eye disorder which clouds the lens, and as a result, leads to defects in vision. Cataract is among the most common diseases which lead to blindness, reducing vision ability. Cataract is known to develop slowly and affects either one or both the eyes. 
Cataract does not directly interfere with the eyesight in its early stages; nevertheless, it interferes with vision and leads blindness over the years. The symptoms of cataract are blurry vision, trouble with bright lights, faded colors, and night blindness. Cataract surgery is among the most common ophthalmic procedures; therefore, potential for the growth of cataract surgery devices is unprecedented.

Cataract Surgery is a process used to remove the eye’s clouded natural lens and replace the same with an artificial lens to restore vision. If cataract is not removed surgically, it is possible to suffer from blurred vision, if not complete blindness. Surgery is the only way to fully restore vision. The cataract operation is generally an outpatient procedure, where the patients are discharged immediately after the surgery. Cataracts are the common cause for impaired vision and are particularly impacting people in the developing countries, where they commonly lead to blindness. The risk of cataract increases with each decade of life starting at the age of 40. By the age of 75, it is estimated that half of Americans have cataract. By age 80, 70 percent of American population has cataract.
 

Cataract Surgery Devices Market Size

Global Cataract Surgery Devices Market Size

 

Click Here For Free Insights

Based on Type, the market is segmented into Consumables and Equipment. Based on Product, the market is segmented into Ophthalmic Viscoelastic Device (OVD), Intraocular Lens (IOL) and Phacoemulsification Equipment. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Ophthalmology Clinics. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Cataract Surgery Devices Market Share

Global Cataract Surgery Devices Market Share

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis Ag, Abbott Laboratories, Carl Zeiss Meditec Ag, Essilor International S.A, Johnson & Johnson, Metall Zug AG, Topcon Corporation, Nidek Co., Ltd, Valeant Pharmaceuticals International, Inc. and Ziemer Ophthalmic Systems Ag.

Scope of the Study

Market Segmentation:

By Type

  • Consumables
  • Equipment

By Product

  • Ophthalmic Viscoelastic Device (OVD)
  • Intraocular Lens (IOL)
  • Phacoemulsification Equipment.

By End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs) and
  • Ophthalmology Clinics

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Novartis Ag
  • Abbott Laboratories
  • Carl Zeiss Meditec Ag
  • Essilor International S.A
  • Johnson & Johnson
  • Metall Zug AG
  • Topcon Corporation
  • Nidek Co., Ltd
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems Ag

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo